MoneyWorks4Me

Gland Pharma informs about monitoring agency report

22 Jan 2022 Evaluate

Pursuant to Regulation 41(4) of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 and Regulation 32(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Gland Pharma has informed that it enclosed Monitoring Agency Report dated January 21, 2022 in respect of utilization of proceeds of IPO for the quarter ended December 31, 2021 issued by Axis Bank, Monitoring Agency.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1868.00
Dr. Reddys Labs. 1202.00
Cipla 1385.00
Lupin 2120.00
Zydus Lifesciences 1161.50
View more..